HomeBusinessGSK COVID antiviral authorization for sotrovimab revoked by FDA GSK COVID antiviral authorization for sotrovimab revoked by FDA By gobspk 12/23/2024 FacebookTwitterPinterestWhatsApp GSK COVID antiviral authorization for sotrovimab revoked by FDA Share this:FacebookX Previous articlePFX stock hits 52-week high, soaring to $50.5 amid market rally By Investing.comNext articlePopular Weight Loss Drug Zepbound Gains FDA Approval to Treat Sleep Apnea latest articles ConnectM technology solutions executive buys $898.7m in stock By Investing.com Marcus & Millichap Closes 31 Property Net Lease Portfolio for $88.5 Million By Investing.com UK launches review of targets for sales of electric vehicles Wayfair CEO Niraj Shah sells $1.37 million in company stock By Investing.com Jack in the box SVP sells shares worth $49,312 By Investing.com Jack in the box CTO sells shares worth $54,661 By Investing.com explore more ConnectM technology solutions executive buys $898.7m in stock By Investing.com Marcus & Millichap Closes 31 Property Net Lease Portfolio for $88.5 Million By Investing.com UK launches review of targets for sales of electric vehicles Wayfair CEO Niraj Shah sells $1.37 million in company stock By Investing.com Jack in the box SVP sells shares worth $49,312 By Investing.com Jack in the box CTO sells shares worth $54,661 By Investing.com Leave A Reply Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. Δ